Liposomal daunorubicin (Daunoxome) in the treatment of acute lymphocytic leukemia (ALL).

被引：0
|
作者：
Baccarani, M [1 ]
Russo, D [1 ]
Fanin, R [1 ]
Michieli, M [1 ]
机构：
[1] Univ Hosp, Div Hematol, Udine, Italy
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3110
引用
收藏
页码：720A / 720A
页数：1
相关论文
共 50 条
  • [11] Combination of liposomal daunorubicin (DaunoXome), fludarabine, and cytarabine (FLAD) in patients with poor-risk acute leukemia
    Clavio, M
    Venturino, C
    Pierri, I
    Garrone, A
    Miglino, M
    Canepa, L
    Balleari, E
    Balocco, M
    Michelis, G
    Ballerini, F
    Gobbi, M
    ANNALS OF HEMATOLOGY, 2004, 83 (11) : 696 - 703
  • [12] Combination of liposomal daunorubicin (daunoXome), fludarabine and cytarabine as salvage therapy in relapsed and refractory acute leukemia.
    Pierri, I
    Miglino, M
    Gatto, S
    Venturini, C
    Quintino, S
    Beltrami, G
    Lanino, E
    Clavio, M
    Canepa, L
    Gobbi, M
    BLOOD, 2000, 96 (11) : 215B - 215B
  • [13] Liposomal daunorubicin (Daunoxome®) for childhood acute lymphoblastic leukemia:: A phase I-II study.
    Baruchel, A
    Auvrignon, A
    Perel, Y
    Leblanc, T
    Landman, J
    Bertrand, Y
    Gandemer, V
    Mechinaud, F
    Michel, G
    Robert, J
    Leverger, G
    Schaison, G
    BLOOD, 1998, 92 (10) : 234A - 234A
  • [14] Combinations of topotecan and liposomal daunorubicin (Daunoxome) in refractory acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).
    Giles, FJ
    Kantarjian, HM
    Cortes, JE
    Koller, C
    Thomas, D
    O'Brien, SM
    Estey, E
    Beran, M
    BLOOD, 1999, 94 (10) : 230B - 230B
  • [15] Combination of liposomal daunorubicin (DaunoXome), fludarabine, and cytarabine (FLAD) in patients with poor-risk acute leukemia
    Marino Clavio
    Claudia Venturino
    Ivana Pierri
    Alberto Garrone
    Maurizio Miglino
    Letizia Canepa
    Enrico Balleari
    Manuela Balocco
    Gian Luca Michelis
    Filippo Ballerini
    Marco Gobbi
    Annals of Hematology, 2004, 83 : 696 - 703
  • [16] Treatment of relapsed and resistant lymphoma with liposomal daunorubicin (Daunoxome(R), Nexstar)
    Richardson, DS
    Tighe, M
    Johnson, SA
    Kelsey, SM
    Newland, AC
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 63 - 63
  • [17] Treatment of newly diagnosed acute myelogenous leukemia adults younger than age 56 with liposomal daunorubicin (DaunoXome) and ARA-C.
    Douer, D
    Mohrbacher, A
    Watkins, K
    Rutledge, P
    Onetto, N
    Levine, A
    BLOOD, 2001, 98 (11) : 211B - 212B
  • [18] Treatment of newly diagnosed acute myelogenous leukemia adults younger than age 55 with liposomal daunorubicin (DaunoXome) and ARA-C.
    Douer, D
    Mohrbacher, A
    Watkins, K
    Rutledge, P
    Onetto, N
    BLOOD, 2000, 96 (11) : 210B - 210B
  • [19] DAUNORUBICIN (DNR) CARDIAC TOXICITY IN CHILDREN WITH ACUTE LYMPHOCYTIC LEUKEMIA (ALL)
    HALAZUN, JF
    SINKS, LF
    WAGNER, HR
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1972, 13 (MAR): : 61 - &
  • [20] Phase I study of liposomal daunorubicin (Daunoxome) in the treatment of metastatic breast cancer
    Thomas, A
    Shields, F
    Wells-Jordan, P
    Lloyd, D
    Hubbard, A
    Steward, WP
    O'Byrne, KJ
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S293 - S293
12345